ResMed (RMD)
(Delayed Data from NYSE)
$197.04 USD
-11.30 (-5.42%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $197.20 +0.16 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 481 - 500 ( 531 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q3 FY2015 slight miss as mix shifts to flow generators; maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q1 CY2015 Feltl CPAP Project 2005-2015: 16,000+ patient survey
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q2 FY2015 beats handily on strong international, flow generators; maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q4 CY2014 Feltl CPAP Project 2005-2014: 15,000+ patient survey
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q4 CY2014 Feltl CPAP Project 2005-2014: 15,000+ patient survey
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q2 CY2014 CPAP Project 2005-2013: ~15,000 patient survey
Provider: Feltl & Company
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q4 FY2014 disappointed, Americas weak again, maintain HOLD
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Roughly inline Q3 FY2014, Americas weak again, maintain HOLD
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q1 CY2014 Feltl CPAP Project 2005-2013:14,000 patient survey
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Turns in disappointing Q2 FY2014, maintain HOLD, lower PT to $44.00
Provider: FELTL & COMPANY
Analyst: HAYNOR B